NeoGenomics (NEO) Financials

$16.61

$-0.54 (-3.15%)

As on 05-Nov-2026 11:35EST

Market cap

$2,249 Mln

Revenue (TTM)

$788 Mln

P/E Ratio

--

P/B Ratio

2.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	787.75	727.33	660.57	591.64	509.73	484.33
Cost of Revenue	442.71	444.79	370.47	347.04	321.83	297.27
Gross Profit	345.04	282.54	290.10	244.60	187.90	187.06
Operating Expenses	392.14	348.62	382.21	352.34	345.52	305.81
Operating Profit (EBIT)	-47.09	-66.08	-92.11	-107.74	-157.62	-118.75
Other Income	--	--	--	--	-0.21	-0.50
Profit before Tax	-36.18	-110.27	-80.68	-97.10	-159.34	-15.08
Provision for Tax	-3.88	-2.24	-1.95	-9.13	-15.09	-6.73
Profit after Tax (Net Income)	-32.30	-108.03	-78.73	-87.97	-144.25	-8.35
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-144.25	-8.35

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	800.64	836.56	902.34	941.54	998.02	1,108.28
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	460.11	434.97	434.46	643.39	652.08	674.27
Current Liabilities	116.17	88.30	301.24	96.30	89.93	87.23
Total Liabilities	1,493.09	1,359.83	1,638.04	1,681.23	1,740.03	1,869.78

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	966.83	983.54	1,042.02	1,084.42	1,134.74	1,188.27
Current Assets	410.08	376.29	596.02	596.81	605.29	681.51
Total Assets	1,493.09	1,359.83	1,638.04	1,681.23	1,740.03	1,869.78
Total Debt*	449.14	472.28	605.33	611.68	610.93	612.79
Net Current Assets	293.91	287.99	294.78	500.51	515.36	594.28

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	5.23	7.02	-1.95	-65.99	-26.72
Cash Flow from Investing Activities	--	-12.34	12.86	76.71	0.52	-632.37
Cash from Financing Activities	--	-200.29	4.65	4.55	11.83	725.29
Net Cash Inflow / Outflow	--	--	--	--	-53.65	66.20

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.25	-0.84	-0.62	-0.70	-1.16	-0.07
Cash EPS ($)	--	-0.31	-0.05	-0.12	-0.60	0.37
Adjusted Book Value ($)	--	6.50	7.12	7.48	8.00	9.00
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.04	0.06	-0.02	-0.53	-0.22
Free Cash Flow per Share ($)	--	-0.17	-0.27	-0.24	-0.78	-0.74

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-7.67	-5.14	-5.56	-8.66	-0.63
ROE (%)	-3.96	-12.42	-8.54	-9.07	-13.70	-0.93
ROA (%)	-2.18	-7.21	-4.74	-5.14	-7.99	-0.58
EBIT Margin (%)	-4.18	-14.64	-11.21	-15.24	-29.77	-1.42
Net Margin (%)	-4.10	-14.85	-11.92	-14.87	-28.31	-1.73
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	11.08	0.10	0.12	0.16	0.05	0.09
EBIT Growth (%)	70.01	-43.83	17.89	40.57	-2,113.87	2.59
Net Profit Growth (%)	71.54	-37.22	10.51	39.02	-1,628.17	-300.07
EPS Growth (%)	71.79	-0.35	0.11	0.40	-16.06	-2.86
Book Value Growth (%)	-4.99	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-14.01	-26.51	-23.16	-7.99	-503.12
Price / Book Value	2.81	1.81	2.31	2.16	1.15	3.79
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	79.26	-47.18	-1,526.02	-126.88	-16.10	92.41
Close Price ($)	18.36	11.76	16.48	16.18	9.24	34.12
High Price ($)	20.03	19.12	19.00	21.22	35.34	61.57
Low Price ($)	7.07	4.72	12.77	8.71	6.00	29.66
Market Cap ($ Cr)	2,248.79	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.47	0.56	0.67	0.65	0.61	0.55
Short term debt to equity ratio	0.01	0.01	0.23	0.01	0.01	0.01
Current Ratio	3.53	4.26	1.98	6.20	6.73	7.81
Quick Ratio	3.31	3.94	1.89	5.95	6.46	7.54
Interest Coverage	-10.15	-28.38	-11.19	-13.06	-20.02	-0.83

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	27.09	21.89	22.79	22.19	23.49	23.15
Asset Turnover	0.53	0.49	0.40	0.35	0.28	0.34
Receivable days	--	77.78	77.91	77.47	83.06	82.57
Inventory Days	--	22.71	25.09	25.49	27.05	32.51
Payable days	--	18.35	20.68	21.49	21.81	26.35
Cash Conversion Cycle	--	82.14	82.33	81.46	88.31	88.73

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.